top of page

Pavaka Pitches as a Wound Shark Finalist at the 2026 Wound Healing Society Annual Meeting

Writer: Brent Toto
Brent Toto
Apr 8
2 min read

Updated: 5 days ago

CHARLOTTE, N.C. — April 8, 2026 — Pavaka Wound Care pitched today as a finalist in the Wound Shark competition at the Wound Healing Society's 2026 Annual Meeting, held with the Symposium on Advanced Wound Care (SAWC) Spring at the Charlotte Convention Center.


Brent Toto presents Pavaka Wound Care at the Wound Shark Tank session, SAWC Spring / WHS

The Wound Healing Society notified Pavaka of its selection on February 26, 2026. Its submission, "Pavaka's Electroceutical Advanced Wound Dressing: A Next-Generation Solution for Biofilm and MDR Infections," was one of four finalists chosen from 22 submissions.


Wound Shark gives innovators a stage to present new wound care technologies to a panel of judges and an audience of clinicians, scientists and industry leaders. Finalists pitch their technology and development plan, then take questions from the panel.


CEO and Co-Founder Brent Toto presented for Pavaka. He described the clinical burden of chronic and acute wounds complicated by multidrug-resistant bacteria and biofilms, and introduced the company's investigational electroceutical dressing, which generates a low-level electric field at the wound surface and is built on technology exclusively licensed from The Ohio State University. He also outlined the company's development path, including design-for-manufacturing work on its second-generation dressing and its regulatory planning.


The WHS Annual Meeting and SAWC Spring bring together wound care clinicians, researchers and industry. Being selected as a finalist put Pavaka in front of the audience most likely to shape how electroceutical dressings are studied and adopted.


Pavaka thanks the Wound Healing Society, the Wound Shark judges and organizers, and everyone who attended the session.


The Wound Shark pitch came a month after the company exhibited at OPMED 2026 in San Antonio, extending its outreach from military medicine to the broader wound care research community.


"Being chosen as one of four finalists by the Wound Healing Society, the people who define the science of wound care, was an honor. We left Charlotte with new relationships and sharp feedback we're already putting to work." — Brent Toto, CEO and Co-Founder

Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.


About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Sources and further reading

Comments


bottom of page